{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:23:58Z","timestamp":1792596238755,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Preeclampsia (PE), an obstetric disorder, remains one of the leading causes of maternal and infant mortality worldwide. In individuals with PE, the coagulation-fibrinolytic system is believed to be among the most significantly impacted systems due to maternal inflammatory responses and immune dysfunction. Therefore, this systematic review and meta-analysis aimed to assess the association of prothrombin time (PT), thrombin time (TT) and activated partial thromboplastin time (APTT) levels with preeclampsia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This systematic review and meta-analysis was conducted in accordance with the PRISMA guidelines. Articles relevant to the study, published from July 26, 2013, to July 26, 2023, were systematically searched across various databases including PubMed, Scopus, Embase, and Hinari. The methodological quality of the articles was evaluated using the Joanna Briggs Institute critical appraisal checklist. Utilizing Stata version 14.0, a random-effects model was employed to estimate the pooled standardized mean difference (SMD) along with the respective 95% CIs. The I<jats:sup>2<\/jats:sup> statistics and Cochrane Q test were utilized to assess heterogeneity, while subgroup analyses were performed to explore its sources. Furthermore, Egger\u2019s regression test and funnel plot were employed to assess publication bias among the included studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 30 articles, involving 5,964 individuals (2,883 with PE and 3,081 as normotensive pregnant mothers), were included in this study. The overall pooled SMD for PT, APTT, and TT between PE and normotensive pregnant mothers were 0.97 (95% CI: 0.65\u20131.29, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), 1.05 (95% CI: 0.74\u20131.36, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and 0.30 (95% CI: -0.08-0.69, <jats:italic>p<\/jats:italic>\u2009=\u20090.11), respectively. The pooled SMD indicates a significant increase in PT and APTT levels among PE patients compared to normotensive pregnant mothers, while the increase in TT levels among PE patients was not statistically significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The meta-analysis underscores the association between PE and prolonged PT and APTT. This suggests that evaluating coagulation parameters like PT, APTT, and TT in pregnant women could offer easily accessible and cost-effective clinical indicators for assessing PE. However, multicenter longitudinal studies are needed to evaluate their effectiveness across various gestational weeks of pregnancy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-024-06543-7","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T13:02:38Z","timestamp":1715605358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Ermiyas","family":"Alemayehu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousman","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melaku Ashagrie","family":"Belete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewudu","family":"Mulatie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habtu","family":"Debash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemu","family":"Gedefie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Gebretsadik","family":"Weldehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruktawit","family":"Eshetu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agumas","family":"Shibabaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba Gebremichael","family":"Tekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihret","family":"Tilahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussen","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"issue":"6","key":"6543_CR1","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"American College of Obstetricians and Gynecologists","year":"2020","unstructured":"American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237\u201360.","journal-title":"Obstet Gynecol"},{"key":"6543_CR2","doi-asserted-by":"crossref","unstructured":"Kongwattanakul K, Saksiriwuttho P, Chaiyarach S, Thepsuthammarat K. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome. Int J women\u2019s health. 2018:371\u20137.","DOI":"10.2147\/IJWH.S168569"},{"key":"6543_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148\u201369.","journal-title":"Pregnancy Hypertens"},{"issue":"Suppl 1","key":"6543_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl 1):1.","journal-title":"Int J Gynaecol Obstet"},{"issue":"17","key":"6543_CR5","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.3390\/ijms20174246","volume":"20","author":"T Tomimatsu","year":"2019","unstructured":"Tomimatsu T, Mimura K, Matsuzaki S, Endo M, Kumasawa K, Kimura T. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Int J Mol Sci. 2019;20(17):4246.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6543_CR6","first-page":"46","volume":"9","author":"O Efe","year":"2022","unstructured":"Efe O, Benedict N. The association between thrombin antithrombin complex and maternal outcomes in women with preeclampsia-eclampsia at the University of Benin Teaching Hospital, Benin City, Nigeria. J Med Dent Sci Res. 2022;9(12):46\u201357.","journal-title":"J Med Dent Sci Res"},{"key":"6543_CR7","doi-asserted-by":"crossref","unstructured":"Amaral LM, Cunningham MW Jr, Cornelius DC, LaMarca B. Preeclampsia: long-term consequences for vascular health. Vascular health and risk management. 2015:403\u2009\u2013\u200915.","DOI":"10.2147\/VHRM.S64798"},{"issue":"4","key":"6543_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/10641955.2016.1212872","volume":"35","author":"J Milosevic-Stevanovic","year":"2016","unstructured":"Milosevic-Stevanovic J, Krstic M, Radovic-Janosevic D, Stefanovic M, Antic V, Djordjevic I. Preeclampsia with and without intrauterine growth restriction\u2013two pathogenetically different entities? Hypertens Pregnancy. 2016;35(4):573\u201382.","journal-title":"Hypertens Pregnancy"},{"issue":"1","key":"6543_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5455\/medarh.2016.70.44-47","volume":"70","author":"R Dacaj","year":"2016","unstructured":"Dacaj R, Izetbegovic S, Stojkanovic G, Dreshaj S. Elevated liver enzymes in cases of preeclampsia and intrauterine growth restriction. Med Archives. 2016;70(1):44.","journal-title":"Med Archives"},{"key":"6543_CR10","doi-asserted-by":"crossref","unstructured":"Ren H, Liu W, Niu A, Zhao X. Fibrinogen to albumin ratio, a novel serum indicator for evaluating the severity of preeclampsia: a single-center retrospective study. Medicine. 2023;102(13).","DOI":"10.1097\/MD.0000000000033419"},{"key":"6543_CR11","doi-asserted-by":"crossref","unstructured":"Rambaldi MP, Weiner E, Mecacci F, Bar J, Petraglia F. Immunomodulation and preeclampsia. Best practice & research Clinical obstetrics & gynaecology. 2019;60:87\u201396.","DOI":"10.1016\/j.bpobgyn.2019.06.005"},{"key":"6543_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.theriogenology.2017.04.023","volume":"97","author":"S Klainbart","year":"2017","unstructured":"Klainbart S, Slon A, Kelmer E, Bdolah-Abram T, Raz T, Segev G, et al. Global hemostasis in healthy bitches during pregnancy and at different estrous cycle stages: evaluation of routine hemostatic tests and thromboelastometry. Theriogenology. 2017;97:57\u201366.","journal-title":"Theriogenology"},{"issue":"2","key":"6543_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cll.2016.01.007","volume":"36","author":"A Rodriguez","year":"2016","unstructured":"Rodriguez A, Tuuli MG, Odibo AO. First-, second-, and third-trimester screening for preeclampsia and intrauterine growth restriction. Clin Lab Med. 2016;36(2):331\u201351.","journal-title":"Clin Lab Med"},{"issue":"2","key":"6543_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-2001-14072","volume":"27","author":"T Kobayashi","year":"2001","unstructured":"Kobayashi T, Tokunaga N, Sugimura M, Kanayama N, Terao T. editors. 2001 Predictive values of coagulation\/fibrinolysis parameters for the termination of pregnancy complicated by severe preeclampsia. Semin Thromb Hemost 27 2 137\u201342.","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"6543_CR15","first-page":"BE01","volume":"8","author":"M Kar","year":"2014","unstructured":"Kar M. Role of biomarkers in early detection of preeclampsia. J Clin Diagn Research: JCDR. 2014;8(4):BE01.","journal-title":"J Clin Diagn Research: JCDR"},{"key":"6543_CR16","first-page":"146","volume":"35","author":"X Na","year":"2019","unstructured":"Na X, Xia Y. Thromboelastic diagram and clotting evaluation of low molecular weight heparin in improving clotting function in patients with severe preeclampsia. J Obstet Gynecol. 2019;35:146\u20139.","journal-title":"J Obstet Gynecol"},{"issue":"6","key":"6543_CR17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/medicina59061169","volume":"59","author":"RC Santoro","year":"2023","unstructured":"Santoro RC, Molinari AC, Leotta M, Martini T. Isolated prolongation of activated partial thromboplastin time: not just rleeding risk! Medicina. 2023;59(6):1169.","journal-title":"Medicina"},{"issue":"3","key":"6543_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5045\/br.2016.51.3.171","volume":"51","author":"J-H Byun","year":"2016","unstructured":"Byun J-H, Jang I-S, Kim JW, Koh E-H. Establishing the heparin therapeutic range using aPTT and anti-xa measurements for monitoring unfractionated heparin therapy. Blood Res. 2016;51(3):171.","journal-title":"Blood Res"},{"issue":"05","key":"6543_CR19","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1055\/a-1261-3884","volume":"40","author":"S Li","year":"2020","unstructured":"Li S, Wang M, Li X, Xu Q, Liu S, Luo S, et al. Analysis of an inherited dysfibrinogenemia pedigree associated with a heterozygous mutation in the FGA Gene. H\u00e4mostaseologie. 2020;40(05):642\u20138.","journal-title":"H\u00e4mostaseologie"},{"issue":"2","key":"6543_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/MBC.0000000000001000","volume":"32","author":"R Marchi","year":"2021","unstructured":"Marchi R, Neerman-Arbez M, Gay V, Mourey G, Fiore M, Mouton C, et al. Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls. Blood Coagul Fibrinolysis. 2021;32(2):108\u201314.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"6543_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cll.2014.06.005","volume":"34","author":"JH Levy","year":"2014","unstructured":"Levy JH, Szlam F, Wolberg AS, Winkler A. Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clin Lab Med. 2014;34(3):453\u201377.","journal-title":"Clin Lab Med"},{"issue":"1","key":"6543_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amjms.2017.03.012","volume":"354","author":"Y Chen","year":"2017","unstructured":"Chen Y, Lin L. Potential value of coagulation parameters for suggesting preeclampsia during the third trimester of pregnancy. Am J Med Sci. 2017;354(1):39\u201343.","journal-title":"Am J Med Sci"},{"issue":"12","key":"6543_CR23","doi-asserted-by":"publisher","first-page":"e114488","DOI":"10.1371\/journal.pone.0114488","volume":"9","author":"L Han","year":"2014","unstructured":"Han L, Liu X, Li H, Zou J, Yang Z, Han J, et al. Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PLoS ONE. 2014;9(12):e114488.","journal-title":"PLoS ONE"},{"issue":"1","key":"6543_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12884-022-05335-1","volume":"23","author":"HX Cui","year":"2023","unstructured":"Cui HX, Chen C, Jung YM, Guo ZY, Dong CY, Lee SM, et al. Neutrophil-to-lymphocyte ratio (NLR) as a predictive index for liver and coagulation dysfunction in preeclampsia patients. BMC Pregnancy Childbirth. 2023;23(1):4.","journal-title":"BMC Pregnancy Childbirth"},{"key":"6543_CR25","unstructured":"Han Q, Zheng W, Guo X-D, Zhang D, Liu H-F, Yu L et al. A new predicting model of preeclampsia based on peripheral blood test values. Eur Rev Med Pharmacol Sci. 2020;24(13)."},{"key":"6543_CR26","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.","journal-title":"Int J Surg"},{"key":"6543_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:1\u201313.","journal-title":"BMC Med Res Methodol"},{"key":"6543_CR28","first-page":"217","volume":"5","author":"S Moola","year":"2017","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: systematic reviews of etiology and risk. Joanna Briggs Inst Reviewer\u2019s Man Joanna Briggs Inst. 2017;5:217\u201369.","journal-title":"Joanna Briggs Inst Reviewer\u2019s Man Joanna Briggs Inst"},{"issue":"11","key":"6543_CR29","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"10","key":"6543_CR30","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","volume":"54","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046\u201355.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"6543_CR31","first-page":"12936","volume":"12","author":"L Chen","year":"2019","unstructured":"Chen L, Cai X, Yan J, Chen R, Zhang H, Liu H, et al. Clinical research on maternal platelet parameters and indicators of coagulation function in complication of preeclampsia-eclampsia. Int J Clin Exp Med. 2019;12(11):12936\u201342.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"6543_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1515\/biol-2019-0037","volume":"14","author":"H Lidan","year":"2019","unstructured":"Lidan H, Jianbo W, Liqin G, Jifen H, Lin L, Xiuyan W. The diagnostic efficacy of thrombelastography (TEG) in patients with preeclampsia and its association with blood coagulation. Open Life Sci. 2019;14(1):335\u201341.","journal-title":"Open Life Sci"},{"issue":"22","key":"6543_CR33","first-page":"2698","volume":"22","author":"D Ren","year":"2019","unstructured":"Ren D, Wang Y. Assistant diagnosis for coagulation function and platelet parameters in the diagnosis of preeclampsia and its severity. Chin Gen Pract. 2019;22(22):2698.","journal-title":"Chin Gen Pract"},{"key":"6543_CR34","doi-asserted-by":"crossref","unstructured":"Xu C, Li Y, Zhang W, Wang Q. Analysis of perinatal coagulation function in preeclampsia. Medicine. 2021;100(26).","DOI":"10.1097\/MD.0000000000026482"},{"key":"6543_CR35","doi-asserted-by":"crossref","unstructured":"Jin P-P, Ding N, Dai J, Liu X-Y, Mao P-M. Investigation of the relationship between changes in maternal coagulation profile in the first trimester and the risk of developing preeclampsia. Heliyon. 2023;9(7).","DOI":"10.1016\/j.heliyon.2023.e17983"},{"issue":"12","key":"6543_CR36","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.14260\/jemds\/2014\/2268","volume":"3","author":"P Chauhan","year":"2014","unstructured":"Chauhan P, Rawat U, Bisht V, Purohit R. Comparison of cogulation profile in pre eclamptic and eclamptic patients with normotensive pregnant patients. J Evol Med Dent Sci. 2014;3(12):3208\u201316.","journal-title":"J Evol Med Dent Sci"},{"key":"6543_CR37","doi-asserted-by":"crossref","unstructured":"R A. A study of fibrinogen, prothrombin time, serum transaminases in normal pregnancy, preeclampsia and their significance as a diagnostic tool among preeclampsia patients. J Evidence-Based Med Healthc. 2015;2(60).","DOI":"10.18410\/jebmh\/2015\/1273"},{"key":"6543_CR38","doi-asserted-by":"publisher","first-page":"13456","DOI":"10.18535\/jmscr\/v4i10.112","volume":"4","author":"S Chaudhary","year":"2016","unstructured":"Chaudhary S, Baxi S. Study of coagulation profile in patients of pregnancy induced hypertension-a single centric prospective study. J Med Sci Clin Res. 2016;4:13456\u201362.","journal-title":"J Med Sci Clin Res"},{"key":"6543_CR39","doi-asserted-by":"crossref","unstructured":"Chaware SA, Birare SD, Naigaonkar NV, Mahule SK. Comparative study of coagulation profile in pre-eclamptic and eclamptic patients with normotensive pregnant patients: 2 year study. Indian J Pathology: Res Pract. 2017;6(2).","DOI":"10.21088\/ijprp.2278.148X.62(pt-II)17.19"},{"issue":"3","key":"6543_CR40","first-page":"12","volume":"6","author":"T Bhavana","year":"2018","unstructured":"Bhavana T, Kulkarni V, Prashant T. Coagulation profile in pregnancy induced hypertension. J Contemp Med Dentistry. 2018;6(3):12\u20137.","journal-title":"J Contemp Med Dentistry"},{"issue":"3","key":"6543_CR41","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.18203\/2320-6012.ijrms20200790","volume":"8","author":"B Haldar","year":"2020","unstructured":"Haldar B, Barui G. Study of coagulation profile and platelet indices in pregnancy induced hypertension with special reference to preeclamptic and eclamptic patients. Int J Res Med Sci. 2020;8(3):1114\u20138.","journal-title":"Int J Res Med Sci"},{"issue":"2","key":"6543_CR42","first-page":"PO07","volume":"9","author":"G Dundy","year":"2020","unstructured":"Dundy G, Kumar H, Chaurasia SK, Singh S. Comparison study of coagulation profile in normal term pregnancy and pregnancy induced hypertension. Natl J Lab Med. 2020;9(2):PO07\u201310.","journal-title":"Natl J Lab Med"},{"issue":"14","key":"6543_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.31782\/IJCRR.2021.131404","volume":"13","author":"BAS Sharma","year":"2021","unstructured":"Sharma BAS, Kumar R, Bali IK. Platelet and coagulation parameters in pregnancy induced hypertension and eclampsia \u2013 a tertiary hospital-based study. Int J Curr Res Rev. 2021;13(14):85\u201392.","journal-title":"Int J Curr Res Rev"},{"key":"6543_CR44","doi-asserted-by":"publisher","first-page":"104124","DOI":"10.1016\/j.amsu.2022.104124","volume":"80","author":"N Bhutani","year":"2022","unstructured":"Bhutani N, Jethani V, Jethani S, Ratwani K. Coagulation profile and platelet parameters in pregnancy induced hypertension cases and normotensive pregnancies: a cross-sectional study. Annals Med Surg. 2022;80:104124.","journal-title":"Annals Med Surg"},{"issue":"9","key":"6543_CR45","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.18203\/2320-1770.ijrcog20222089","volume":"11","author":"PGS Indora","year":"2022","unstructured":"Indora PGS, Agarwal P. A comparative study of coagulation profile and platelet indices at term in pre-eclamptic, eclamptic and normal pregnancy along with fetomaternal outcome. Int J Reprod Contracept Obstet Gynecol. 2022;11(9):2368\u201374.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"1","key":"6543_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5005\/jp-journals-10006-2192","volume":"15","author":"S Tadu","year":"2023","unstructured":"Tadu S, Yerroju K, Gudey S. A comparative study of coagulation profile in normal pregnancy, mild preeclampsia, and severe preeclampsia patients. J South Asian Federation Obstet Gynecol. 2023;15(1):71\u20135.","journal-title":"J South Asian Federation Obstet Gynecol"},{"issue":"4","key":"6543_CR47","first-page":"1723","volume":"12","author":"MNS Khan","year":"2018","unstructured":"Khan MNS, Hameed A, Hassan A, Khan J, Ashraf S. Comparison of platelet count, platelet indices and coagulation profile in preeclampsia and normal pregnancy. Pak J Med Health Sci. 2018;12(4):1723\u20136.","journal-title":"Pak J Med Health Sci"},{"issue":"11","key":"6543_CR48","first-page":"2048","volume":"70","author":"G Shaheen","year":"2020","unstructured":"Shaheen G, Sajid S, Jahan S. Evaluation of coagulation factors and serum ferritin in preeclamptic Pakistani women. JPMA J Pakistan Med Association. 2020;70(11):2048\u201350.","journal-title":"JPMA J Pakistan Med Association"},{"key":"6543_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.12659\/MSMBR.910660","volume":"24","author":"OA Ekun","year":"2018","unstructured":"Ekun OA, Ogidi NO, Lawal RA, Ogunmuyiwa OA, Umewune MC, Adefolaju FO, et al. Interrelationship between markers of oxidative stress, inflammation and hematological parameters among preeclamptic Nigerian women. Med Sci Monit Basic Res. 2018;24:225.","journal-title":"Med Sci Monit Basic Res"},{"issue":"3","key":"6543_CR50","doi-asserted-by":"publisher","first-page":"576","DOI":"10.4314\/ahs.v18i3.15","volume":"18","author":"O Oladosu-Olayiwola","year":"2018","unstructured":"Oladosu-Olayiwola O, Olawumi H, Babatunde A, Ijaiya M, Durotoye I, Biliaminu S, et al. Fibrinolytic proteins of normal pregnancy and pre-eclamptic patients in North West Nigeria. Afr Health Sci. 2018;18(3):576\u201383.","journal-title":"Afr Health Sci"},{"key":"6543_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1182\/blood-2020-137401","volume":"136","author":"E Lefkou","year":"2020","unstructured":"Lefkou E, Van Dreden P, Rousseau A, Gerotziafas GT. Differences in the coagulation profile in women with mild and severe preeclampsia. Blood. 2020;136:15\u20136.","journal-title":"Blood"},{"key":"6543_CR52","unstructured":"Sami SS, Hussein MR. Blood coagulation parameters and platelet indices change in normal and preeclamptic pregnant women, 2022. J Pharm Negat Results. 2022:1128\u201333."},{"issue":"11","key":"6543_CR53","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1515\/cclm-2014-1128","volume":"53","author":"L Spiezia","year":"2015","unstructured":"Spiezia L, Bogana G, Campello E, Maggiolo S, Pelizzaro E, Carbonare CD, et al. Whole blood thromboelastometry profiles in women with preeclampsia. Clin Chem Lab Med (CCLM). 2015;53(11):1793\u20138.","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"6543_CR54","unstructured":"Golovchenko OV, Reshetnikov EA, Aristova IK, Orlova S, Batlutskaya IV, Krikun EN. Clinical and laboratory indicators in pregnant women with preeclampsia. Drug Invention Today. 2018;10."},{"issue":"4","key":"6543_CR55","first-page":"88","volume":"2","author":"A-E Abass","year":"2016","unstructured":"Abass A-E, Adam E, Badwi H, Hassan A, Mohamed R, Izzaldein E, et al. Investigation of some coagulation parameters in pregnant womens with preeclampsia. J Pharm Biol Sci. 2016;2(4):88\u201391.","journal-title":"J Pharm Biol Sci"},{"key":"6543_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cca.2012.10.060","volume":"416","author":"M Pinheiro","year":"2013","unstructured":"Pinheiro M, Gomes K, Dusse L. Fibrinolytic system in preeclampsia. Clin Chim Acta. 2013;416:67\u201371.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"6543_CR57","doi-asserted-by":"publisher","first-page":"e12973","DOI":"10.1111\/aji.12973","volume":"80","author":"MA Kim","year":"2018","unstructured":"Kim MA, Han GH, Kwon JY, Kim YH. Clinical significance of platelet-to\u2010lymphocyte ratio in women with preeclampsia. Am J Reprod Immunol. 2018;80(1):e12973.","journal-title":"Am J Reprod Immunol"},{"key":"6543_CR58","doi-asserted-by":"crossref","unstructured":"Woldeamanuel GG, Tlaye KG, Wu L, Poon LC, Wang CC. Platelet count in preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023:100979.","DOI":"10.1016\/j.ajogmf.2023.100979"},{"issue":"6","key":"6543_CR59","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20150702","volume":"130","author":"AC Harmon","year":"2016","unstructured":"Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW Jr, Wallace K, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci. 2016;130(6):409\u201319.","journal-title":"Clin Sci"},{"issue":"7","key":"6543_CR60","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/14767058.2016.1189897","volume":"30","author":"K Haram","year":"2017","unstructured":"Haram K, Mortensen JH, Mastrolia SA, Erez O. Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know? J Maternal-Fetal Neonatal Med. 2017;30(7):779\u201388.","journal-title":"J Maternal-Fetal Neonatal Med"},{"issue":"1","key":"6543_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-9560-4-4","volume":"4","author":"M Franchini","year":"2006","unstructured":"Franchini M, Lippi G, Manzato F. Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J. 2006;4(1):1\u20139.","journal-title":"Thromb J"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06543-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-024-06543-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06543-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T13:04:54Z","timestamp":1715605494000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-024-06543-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6543"],"URL":"https:\/\/doi.org\/10.1186\/s12884-024-06543-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"11 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}